AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026Net selling: insiders sold $38K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$38K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 6- Open
- $0.83
- 52-wk high
- $4.02
- High
- $0.83
- 52-wk low
- $0.65
- Low
- $0.78
- Prev close
- $0.82
- Mkt cap
- $53.6M
- Volume
- 71.2K
- Fwd P/E
- 8.8x
- P/S
- 1.6x
- P/B
- 3.0x
- Profit margin
- -12.0%
- Op margin
- -42.7%
- ROE
- -21.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about HIT filings
Are insiders buying or selling Health In Tech, Inc. Class A Common Stock (HIT) stock?
Net selling: insiders sold $38K and bought $0 of HIT stock on the open market in the 90 days to Oct 7, 2026, according to SEC Form 4 filings. $11K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Hayes, Timothy (Director), who sold $27K. The latest filing was on Sep 15, 2026.
Which members of Congress have traded HIT recently?
None. No member of Congress disclosed a HIT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this HIT smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
5 funds hold a position and insiders have been net selling.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in HIT right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Company release linked above, where available
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 27, 2026 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2026 | May 13, 2026 | -$0.03 / -$0.02Alpha Vantage | -$0.01 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 25, 2026 | -$0.01 / -$0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 10, 2025 | $0.01 / $0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 21, 2025 | $0.01 / $0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 14, 2025 | $0.01 / $0.01Alpha Vantage | +$0.00 in line | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 17, 2025 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 9, 2026, in 33 days
Financials
Is the business strong?
This company is not yet profitable.
- Net margin
- -12.0%
- Forward P/E
- 8.80
- Market cap
- $54M
Valuation
- P/S1.63
- P/B2.95
Quality
- Operating margin-42.7%
- ROE-21.9%
- ROA-12.7%
Growth
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace